Skip to main content
Recordati Industria Chimica e Farmaceutica S.p.A. (RCDTF)
OTCMKTS · Delayed Price · Currency is USD
56.04
0.00 (0.00%)
Jun 3, 2025, 8:00 PM EDT

RCDTF Revenue

Recordati Industria Chimica e Farmaceutica had revenue of 679.96M EUR in the quarter ending March 31, 2025, with 11.87% growth. This brings the company's revenue in the last twelve months to 2.41B, up 12.85% year-over-year. In the year 2024, Recordati Industria Chimica e Farmaceutica had annual revenue of 2.34B with 12.45% growth.

Revenue (ttm)
2.41B EUR
Revenue Growth
+12.85%
P/S Ratio
4.95
Revenue / Employee
526.66K EUR
Employees
4,583
Market Cap
12.91B USD

Revenue Chart

* This company reports financials in EUR.

History

Fiscal Year End Revenue Change Growth
Dec 31, 20242.34B259.23M12.45%
Dec 31, 20232.08B229.02M12.36%
Dec 31, 20221.85B273.23M17.29%
Dec 31, 20211.58B131.21M9.06%
Dec 31, 20201.45B-32.98M-2.23%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Endo Inc. 1.73B
Veradigm 588.02M
Tian'an Technology Group 1.78M
Elite Pharmaceuticals 70.00M
Glass House Brands 215.62M
Northwest Biotherapeutics 1.47M
American Oncology Network 1.76B
Silence Therapeutics 27.70M
Revenue Rankings

Recordati Industria Chimica e Farmaceutica News

More News